HomeInvestingOptionsBiogen (BIIB) Coming Off Lows After Positive News About Alzheimer's Treatment
Biogen (BIIB) Coming Off Lows After Positive News About Alzheimer's Treatment

Biogen (BIIB) is coming off lows after positive news regarding their new Alzheimer’s treatment drug, says George Tsilis. He talks about how BIIB has been upgraded to overweight Fromm equal weight at Wells Fargo. He also goes over how investors are not valuing royalty streams coming in properly from BIIB. He then demonstrates an example trade using BIIB. Tune in to find out more.

Trading 360

18 Apr 2022

ON AIR
10:00 am
Trading 360
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
ON AIR
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US